Twin Peaks Wealth Advisors, LLC Tg Therapeutics, Inc. Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 385 shares of TGTX stock, worth $14,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
385Holding current value
$14,152% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
406Shares Held
92.4MCall Options Held
2.28MPut Options Held
1.78M-
Vanguard Group Inc Valley Forge, PA15.8MShares$581 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$419 Million0.0% of portfolio
-
State Street Corp Boston, MA7.62MShares$280 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$128 Million0.01% of portfolio
-
Clearbridge Investments, LLC New York, NY3.05MShares$112 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.34B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...